United States · FDA National Drug Code directory
Revonto
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84549-003_463e554f-a0fa-ab45-e063-6294a90abcf6
- Product NDC
- 84549-003
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- dantrolene sodium
- Labeler
- ProPharma Distribution
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210409
- Source listing expiry
- 20261231
Source-listed ingredients
- DANTROLENE SODIUM — 20 mg/60mL
These values do not establish equivalence or a dose recommendation.
Packages
- 60 mL in 1 VIAL, GLASS (84549-003-67) · 84549-003-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →